Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02926378 · ClinicalTrials.gov registry record · NA

Acupuncture for Stroke Recovery

A NA study, sponsored by NYU Langone Health.

Terminated
Registry status
NA
Development phase
3
Enrollment target

NCT02926378: Clinical Trial NA study, sponsored by NYU Langone Health.

NCT02926378 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02926378, a NA study, was terminated before completion, sponsored by NYU Langone Health.

TERMINATED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

Based on the evidence, a pre-post test pilot study design will be implemented to clarify the benefits of an acupuncture intervention before and after treatment. The initial assessment will contain a brief demographic interview and a review of medical records, and both pre and post-intervention evaluations will comprise an imaging protocol that includes RS-fMRI, pCASL, diffusion kurtosis imaging (DKI), and a brief cognitive assessment, as described in greater detail below. Several quantitative measures within DMN regions will be generated and compared between pre- and post-acupuncture therapy. These include 1) RS-fMRI measures such as connectivity strength and fractional amplitude of low frequency fluctuations (fALFF); 2) regional CBF measured with pCASL; 3) water diffusion measures for microstructural changes with DKI.

Primary Outcome

It is difficult to conduct resting state analysis with this small N due to its large inherent variability. Visual analysis, as described below, will be utilized to compare changes in fMRI scans before and after the acupuncture intervention. The fMRI is a self-control comparison in this study.

Interventions

  • PROCEDURE Acupuncture Treatments

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2016-11-18
Est. Completion 2017-06-28
Phase NA
NYU Langone Health

1,164 total trials

Why NCT02926378 stopped before completion

NCT02926378 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Acupuncture Treatments is the first listed.

NCT02926378 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02926378 about?

NCT02926378 is a clinical study titled "Acupuncture for Stroke Recovery". Based on the evidence, a pre-post test pilot study design will be implemented to clarify the benefits of an acupuncture intervention before and after treatment. The initial assessment will contain a brief demographic interview and a review of medical records, and both pre and post-intervention evalu...

What is the current status of trial NCT02926378?

This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2016-11-18. Estimated completion is 2017-06-28.

What interventions are being tested in trial NCT02926378?

The interventions under investigation include: Acupuncture Treatments (PROCEDURE).

Who is sponsoring clinical trial NCT02926378?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02926378's enrollment target sits among peer trials

3 1996th of 2000 higher than 4 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02926378, the US trial registry maintained by the National Library of Medicine. NCT02926378 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.